These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28228799)

  • 21. Perifosine induced release of contents of trans cell-barrier transport efficient liposomes.
    Koklic T
    Chem Phys Lipids; 2014 Oct; 183():50-9. PubMed ID: 24863642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
    Rait AS; Pirollo KF; Xiang L; Ulick D; Chang EH
    Mol Med; 2002 Aug; 8(8):475-86. PubMed ID: 12435858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
    Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
    ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the cellular transport mechanism of cationic, star-shaped polymers and liposomes in HaCat cells.
    Luo HC; Li N; Yan L; Mai KJ; Sun K; Wang W; Lao GJ; Yang C; Zhang LM; Ren M
    Int J Nanomedicine; 2017; 12():1085-1096. PubMed ID: 28223800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An anti-oxidant, α-lipoic acid conjugated oleoyl-sn-phosphatidylcholineas a helper lipid in cationic liposomal formulations.
    Dharmalingam P; Marrapu B; Voshavar C; Nadella R; Rangasami VK; Shaji RV; Abbas S; Prasad RBN; Kaki SS; Marepally S
    Colloids Surf B Biointerfaces; 2017 Apr; 152():133-142. PubMed ID: 28103530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal nanostructures for photosensitizer delivery.
    Jin CS; Zheng G
    Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations.
    Mahato RI; Takakura Y; Hashida M
    Crit Rev Ther Drug Carrier Syst; 1997; 14(2):133-72. PubMed ID: 9107520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems.
    Dianat-Moghadam H; Heidarifard M; Jahanban-Esfahlan R; Panahi Y; Hamishehkar H; Pouremamali F; Rahbarghazi R; Nouri M
    J Control Release; 2018 Oct; 288():62-83. PubMed ID: 30184466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate.
    Djanashvili K; ten Hagen TL; Blangé R; Schipper D; Peters JA; Koning GA
    Bioorg Med Chem; 2011 Feb; 19(3):1123-30. PubMed ID: 20624680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Targeted-liposome Delivery System of Antitumor Drugs.
    Wu WD; Yi XL; Jiang LX; Li YZ; Gao J; Zeng Y; Yi RD; Dai LP; Li W; Ci XY; Si DY; Liu CX
    Curr Drug Metab; 2015; 16(10):894-910. PubMed ID: 26652257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular uptake and localization of liposomal-methylphosphonate oligodeoxynucleotides.
    Tari AM; Andreeff M; Kleine HD; Lopez-Berestein G
    J Mol Med (Berl); 1996 Oct; 74(10):623-8. PubMed ID: 8912183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
    Fukuta T; Kogure K
    Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
    Fathi S; Oyelere AK
    Future Med Chem; 2016 Nov; 8(17):2091-2112. PubMed ID: 27774793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermoresponsive pegylated bubble liposome nanovectors for efficient siRNA delivery via endosomal escape.
    Alamoudi K; Martins P; Croissant JG; Patil S; Omar H; Khashab NM
    Nanomedicine (Lond); 2017 Jun; 12(12):1421-1433. PubMed ID: 28524721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.